Precision cytokine modulation to overcome tumor microenvironment-driven resistance to immune checkpoint blockade.

Immune checkpoint inhibitors (ICIs) can elicit durable remissions, yet most solid tumors show primary non-response or acquired resistance because the tumor microenvironment (TME) limits T-cell priming, trafficking and effector fitness. Cytokines orch…

Preview only. Read the full abstract at the source